Neurophysiology and Pathology of Dementia and Alzheimer’s Disease
K.Malleswari*, D.Rama Brahma Reddy, A M.Manohar, B V.Mahesh,
C M.Hanok
Nalanda Institute of
Pharmaceutical Sciences, Siddharth nagar, Kantepudi (v) Sattenapalli (M) Guntur
Dist -522438
ABSTRACT
Alzheimer's disease is one of the most
devastating brain disorders of elderly humans. It is a decade has witnessed a
steadily increasing effort directed at discovering the etiology of the disease
and developing pharmacological treatment. Recent developments include improved
clinical diagnostic guidelines and improved treatment of both cognitive disturbance
and behavioral problems. Symptomatic treatment mainly focusing on cholinergic
therapy has been clinically evaluated by randomized, double-blind,
placebo-controlled, parallel-group studies measuring performance-based tests of
cognitive function, activities of daily living, and behavior. The role of
estrogen replacement, anti-inflammatory agents, and antioxidants is
controversial and needs further study. Antidepressants, antipsychotics, mood
stabilizers, anxiolytics, and hypnotics are used for the treatment of
behavioral disturbance. Future directions in the research and treatment of
patients with Alzheimer's disease include: applying functional brain imaging
techniques in early diagnosis and evaluation of treatment efficacy; development
of new classes of medications working on different neurotransmitter systems
(cholinergic, glutamatergic, etc.)
Keywords:
Dementia, Symptoms and Stages of disease, Etiology, Pathology, Neurophysiology,
Risk factors, Causes, Diagnosis, Treatment, Prevalence,